FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
831 listings in the last 90 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| Deferiprone | Deferiprone 500 mg/1 | TabletOral | AvKARE | Aug 12, 2026 | 73190-095 |
| Awiqliinsulin icodec-abae | Insulin icodec 700 U/mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | Aug 11, 2026 | 0169-3170 |
| Lidocainelidocaine hydrochloride | Lidocaine hydrochloride 20 mg/mL | JellyTopical | Sentiss Pharmaceuticals LLC | Aug 11, 2026 | 70244-039 |
| Chlorpromazine | Chlorpromazine hydrochloride 100 mg/1 | TabletOral | REMEDYREPACK INC. | Aug 11, 2026 | 70518-4724 |
| Paclitaxel 100mg per vialpaclitaxel protein-bound particles | Paclitaxel 100 mg/20mL | Injection, Powder, Lyophilized, For suspensionIntravenous | EXELAN PHARMACEUTICALS INC. | Aug 11, 2026 | 76282-768 |
| Desmopressin Acetate | Desmopressin acetate 4 ug/mL | Injection, SolutionIntravenous, Subcutaneous | The J. Molner Company LLC | Aug 11, 2026 | 83148-126 |
| vancomycin hydrochloride | Vancomycin hydrochloride 125 mg/1 | CapsuleOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | Aug 10, 2026 | 23155-967 |
| vancomycin hydrochloride | Vancomycin hydrochloride 250 mg/1 | CapsuleOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | Aug 10, 2026 | 23155-968 |
| Nitroglycerin | Nitroglycerin 4 mg/g | OintmentRectal | Padagis Israel Pharmaceuticals Ltd | Aug 10, 2026 | 45802-932 |
| Brivaracetam | Brivaracetam 10 mg/mL | SolutionOral | Aurobindo Pharma Limited | Aug 10, 2026 | 59651-995 |
| Ranolazine | Ranolazine 500 mg/1 | Tablet, Extended releaseOral | Umedica Laboratories USA Inc. | Aug 10, 2026 | 60290-055 |
| Ranolazine | Ranolazine 1000 mg/1 | Tablet, Extended releaseOral | Umedica Laboratories USA Inc. | Aug 10, 2026 | 60290-056 |
| Sacubitril and Valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | Tablet, Film coatedOral | Umedica Laboratories USA Inc. | Aug 10, 2026 | 60290-085 |
| Sacubitril and Valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | Tablet, Film coatedOral | Umedica Laboratories USA Inc. | Aug 10, 2026 | 60290-086 |
| Sacubitril and Valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | Tablet, Film coatedOral | Umedica Laboratories USA Inc. | Aug 10, 2026 | 60290-087 |
| Acamprosate Calcium | Acamprosate calcium 333 mg/1 | Tablet, Delayed releaseOral | Somerset Therapeutics, LLC | Aug 10, 2026 | 70069-860 |
| Ticagrelor | Ticagrelor 60 mg/1 | Tablet, Film coatedOral | NorthStar RxLLC | Aug 10, 2026 | 72603-940 |
| Ticagrelor | Ticagrelor 90 mg/1 | Tablet, Film coatedOral | NorthStar RxLLC | Aug 10, 2026 | 72603-941 |
| Temozolomide | Temozolomide 5 mg/1 | CapsuleOral | CivicaScript LLC | Aug 10, 2026 | 82249-404 |
| Temozolomide | Temozolomide 20 mg/1 | CapsuleOral | CivicaScript LLC | Aug 10, 2026 | 82249-406 |
| Temozolomide | Temozolomide 100 mg/1 | CapsuleOral | CivicaScript LLC | Aug 10, 2026 | 82249-408 |
| Temozolomide | Temozolomide 140 mg/1 | CapsuleOral | CivicaScript LLC | Aug 10, 2026 | 82249-410 |
| Temozolomide | Temozolomide 180 mg/1 | CapsuleOral | CivicaScript LLC | Aug 10, 2026 | 82249-412 |
| Temozolomide | Temozolomide 250 mg/1 | CapsuleOral | CivicaScript LLC | Aug 10, 2026 | 82249-414 |
| Fluconazole | Fluconazole 50 mg/1 | TabletOral | REMEDYREPACK INC. | Aug 8, 2026 | 70518-4723 |